Despite advances in early detection and treatment, invasion and metastasis of breast tumors remains a major 18 hurdle. Cystatin A (CSTA, also called stefin A), an estrogen-regulated gene in breast cancer cells, is an 19 inhibitor of cysteine cathepsins, and a purported tumor suppressor. Loss of CSTA expression in breast 20 tumors evidently shifts the balance in favor of cysteine cathepsins, thereby promoting extracellular matrix 21 remodeling, tumor invasion and metastasis. However, the underlying mechanism behind the loss of CSTA 22 expression in breast tumors is not known. Here, we have analyzed CSTA expression, and methylation of 23 upstream and intron-2 CpG sites within the CSTA locus in human breast cancer cell lines and breast tumors 24 of the TCGA cohort. Results showed an inverse relationship between expression and methylation. Sequence 25 analysis revealed a potential estrogen response element (ERE) in the intron-2. Analysis of ChIP-seq data 26 (ERP000380) and our own ChIP experiments showed that 17β-estradiol (E2) enhanced ERα binding to this 27 ERE in MCF-7 cells. This ERE was located amidst the differentially methylated intron-2 CpG sites, which 28 provoked us to examine the possible conflict between estrogen-regulation of CSTA and DNA methylation 29 in the intron-2. We analyzed the expression of CSTA and its regulation by estrogen in MDA-MB-231 and 30 T47D cells subjected to global demethylation by 5-azacytidine (5-aza). 5-aza, not only enhanced CSTA 31 expression in these cell lines but also restored estrogen-regulation of CSTA in these cells. Taken together, 32 2 our results indicate that DNA methylation-dependent silencing could play a significant role in the loss of 33 CSTA expression in breast tumors. The potential of DNA methylation as an indicator of CSTA expression 34 or as a marker of tumor progression can be explored in future investigations. Furthermore, our results 35 indicate the convergence of ERα-mediated estrogen regulation and DNA methylation in the intron-2, 36 thereby offering a novel context to understand the role of estrogen-ERα signaling axis in breast tumor 37 invasion and metastasis. 38 39
Introduction

43
Cysteine cathepsins are a major group of 11 lysosomal acid hydrolases in humans. The presence of 44 cysteine in their active site distinguishes them from other lysosomal serine-or aspartic cathepsins (Khaket 45 Turk et al., 2012) . Collectively, they hydrolyze proteins within and outside the cell (Turk et 46 al., 2000) . They are involved in various cellular processes, such as protein turnover, antigen presentation, 47 apoptosis, and matrix remodeling (Fonović and Turk, 2014; Turk et al., 2000 Turk et al., , 2012 Vizovišek et al., 2019) .
48
Overt or mislocalized expression of cysteine cathepsins is associated with diverse pathological conditions, 49 including tumors and metastasis (Palermo and Joyce, 2008; Vidak et al., 2019) . Cysteine cathepsins are 50 regulated by compartmentalization, proteolytic cleavage (zymogen activation), pH and endogenous 51 inhibitory proteins called cystatins (Turk et al., 2000 (Turk et al., , 2001 Verma et al., 2016) . Cathepsins and cystatins Cells were seeded in M1 medium. After 24 h, the cells were treated with fresh M1 medium containing 10 126 µM 5-aza for 5 days. Fresh M1 medium with 5-aza was replenished every 48 h. The cells treated with 127 DMSO (vehicle) served as control. 128 2.3.2. E2 treatment on cells subjected to global demethylation 129 MDA-MB-231 or T47D cells were treated with 5-aza as described above, followed by incubation in M2 130 medium for 4 h. Thereafter, the cells were treated with 10 nM E2 or ethanol (vehicle) in M2 medium. After 131 24 h the cells were harvested for isolation of total RNA or protein.
132 133 2.3.3. Treatment of MCF-7 cells with E2 for chromatin immunoprecipitation (ChIP) assay 134 MCF-7 cells were seeded in 100 mm dishes in M1 medium. When the cells were 70 % confluent, the spent 135 medium was replaced with M2 medium and incubated for 24 h. Thereafter, the cells were treated with fresh 136 M2 medium containing 10 nM E2 or ethanol (vehicle). After 24 h, the cells were harvested for ChIP assay. 137 2.4. Routine reverse transcription-polymerase chain reaction (RT-PCR) and quantitative 139 Total RNA was isolated, reverse transcribed and the resultant cDNA was subjected to routine RT-PCR and 140 qRT-PCR analyses with gene-specific primers ( Supplementary table 1) for CSTA, ERα and cyclophilin A 141 (CycA) as previously described (John Mary et al., 2017) . CycA served as an internal control 142 2.5. Western blotting 143 Total protein was isolated from breast cancer cells with Laemmli sample buffer (Laemmli, 1970) or from 144 organic phase of TRIzol lysates and then quantified by TCA method (Karlsson et al., 1994) or Lowry‫׳‬s 145 method (Lowry et al., 1951) respectively. Protein samples (30 µg) were resolved by 12% PAGE, transferred 146 to 0.22 µ nitrocellulose membrane, and blocked with 1% gelatin in TBST for 2 h. Blots were probed with 6 873 samples (85 normal and 788 tumors) had both expression and methylation data. Only the tumor samples 156 were used for analysis. Data were processed in MS Excel. Correlation between methylation (beta values) 157 and CSTA expression (log2RPKM+1) was assessed by Spearman's rank correlation test. Further, tumors 158 were classified into hyper-methylated and hypo-methylated based on a threshold beta-value of 0.3. CSTA 159 expression in hyper-methylated and hypo-methylated tumors was represented as box plots. The difference 160 in CSTA expression in these two groups was analysed by Welch two-sample t-test. 
173
Control and E2-treated MCF-7 cells were fixed with formaldehyde (0.75%) for 10 minutes. The reaction 174 was stopped by 125 mM glycine for 10 minutes. Cells were washed and scraped with ice-cold DPBS, 175 pelleted, lysed with lysis buffer (50 mM HEPES pH 7.5, 150 mM KCl, 1 mM EDTA, 10% glycerol, 0.1% 176 NP-40), and sonicated. Lysates were clarified by centrifugation, and supernatants containing chromatin 177 were collected. Chromatin samples were pre-cleared with Protein G plus-Agarose beads precoated with 178 BSA and herring sperm DNA for 2 h. 5% of the pre-cleared chromatin samples were separated as input.
179
The remaining portions were incubated with ERα antibody or rabbit IgG antibody for 2 h. Samples were 180 immuno-precipitated by incubating with 20 μl of coated beads for 2 h, followed by centrifugation.
181
Immunoprecipitates were washed with a series of wash buffers (Shivaswamy and Iyer, 2007) Galaxy, web-based platform (Afgan et al., 2016) . Chip-Seq data (SRA accession ID: ERP000380) of 190 chromatin samples from MCF-7 cells treated with E2 (ID:ERR022026), tamoxifen (ID:ERR022027) or 191 vehicle (ID:ERR022025) and immuno-precipitated with ERα was chosen for this study. IgG control ChIP-192 seq data was used as the negative control. Using FASTQC tool (Andrews, 2010) , the quality of input reads 193 were assessed. After converting the quality score to sanger quality type by FASTQ Groomer (Blankenberg 194 et al., 2010) , reads were mapped to reference human genome (hg19) using "Map with Bowtie for Illumina" 195 tool (Langmead et al., 2009 ). Unmapped reads were discarded by "Filter SAM or BAM, output SAM or 196 BAM" tool (Li et al., 2009) . Genomic regions with enriched sequencing reads were identified by MACS 197 (Model-based analysis of ChIP-Seq) tool (Zhang et al., 2008) . Resultant Wig files were converted to bigWig 198 files using "Wig/BedGraph-to-bigWig" tool and the peaks representing ERα occupancy were visualized 199 using UCSC genome browser (Kent et al., 2002) . inversely correlated with CSTA expression (Table 1 ). The primary tumors were divided into two groups, 269 namely hypo-and hyper-methylated, using a beta value of 0.3 as a cut-off. CSTA expression in hypo-270 methylated tumors was significantly higher than those in hyper-methylated tumors ( Fig. 4A-D) . We 271 generated a composite methylation score for each sample by averaging the beta values for all the probes.
272
The composite methylation score correlated inversely with CSTA expression (ρ = -0.582, p < 0.0001, Fig In MDA-MB-231 cells, DNA methylation-dependent silencing is the underlying mechanism for 293 the loss of ERα (Lapidus et al., 1998) and CSTA (this study) expression. We examined ERα and CSTA 294 expression in 5-aza-untreated or -pretreated MDA-MB-231 cells, which were stimulated with vehicle or 10 295 nM E2. As expected, in 5-aza-untreated cells, ERα protein expression was not detectable after vehicle or 296 E2 treatment (Fig. 6A, lanes 1 and 2) . There was no significant difference in CSTA mRNA expression ( Fig.   297 6C, bars 1 and 2, ANOVA followed by Tukey's HSD). On the other hand, in 5-aza-pretreated cells, an 298 immunoreactive protein was detected on western blots with ERα specific antibody (Fig. 6A, lanes 3 and 4) .
299
This immunoreactive protein had a higher molecular mass compared to the expected 66 kDa for ERα.
300
Notwithstanding this discrepancy, induction of PR, and further enhancement of its expression with E2 301 confirmed the generation of a functional ERα in 5-aza pretreated cells ( Fig. 6A, B, lanes 3 and 4) . 5-aza 302 significantly induced CSTA mRNA expression in MDA-MB-231 cells (Fig. 6C , bars 1 and 3; ANOVA 303 followed by Tukey's HSD). E2 suppressed the 5-aza induced levels of CSTA mRNA, although the 304 difference was not statistically significant when analyzed by ANOVA. However, the levels of CSTA 305 mRNA in 5-aza pre-treated cells with and without E2 treatment were significantly different when analyzed 306 by the Welch two-sample t-testin ( Fig. 6C , bars 3 and 4, p = 0.0098). Western blots failed to demonstrate We applied the same experimental design to ERα positive T47D cells, which express a very low or 309 undetectable level of CSTA. Without 5-aza pretreatment, T47D cells treated with E2 showed decreased 310 levels of ERα protein and increased levels of PR, as expected ( Fig. 6D , E, lanes 1 and 2) (Al-Dhaheri et al.,
311
2006; Wormke et al., 2000) . There was no observable effect on CSTA protein (Fig. 6D, lanes 1 and 2) .
312
However, we observed an increase in CSTA mRNA (Fig. 6F , bars 1 and 2; ANOVA followed by Tukey's 313 HSD), although the increase was not statistically significant. 5-aza pre-treatment alone caused a decrease 314 in ERα protein in T47D cells (Fig. 6D, lanes 1 and 3) in a manner similar to that reported in MCF-7 cells 315 (Pryzbylkowski et al., 2008) . This also led to increased CSTA (Fig. 6D, lanes 1 and 3) and decreased PR 316 protein expression ( Fig. 6E, lanes 1 and 3) . E2 induction of PR in 5-aza pre-treated T47D cells showed that 317 ERα was functional (Fig. 6E, lanes 3 and 4) . E2 not only enhanced CSTA protein expression ( Fig. 6D , lanes 318 3 and 4), but also significantly enhanced CSTA mRNA in 5-aza pre-treated cells (Fig. 6F, bars 334 Graff et al., 2000; Sathyanarayana et al., 2004 Sathyanarayana et al., , 2003a Sathyanarayana et al., , 2003b Sathyanarayana et al., , 2003c . Hence, our results are not surprising.
335
The conclusions of this study are drawn from results obtained through three different approaches; 336 a) analysis of CSTA expression and methylation data from the TCGA breast cancer cohort, b) examination 337 of DNA methylation data (ENCODE project) for the CSTA locus, and c) bisulfite sequencing of DNA 338 isolated from breast cancer cell lines, which express differential levels of CSTA. TCGA methylation data 339 was generated using the Infinium methylation 450K bead chip arrays, which do not have probes to 12 interrogate all CpG sites in the CSTA locus. Due to this limitation, no conclusion could be drawn regarding 341 the correlation between CSTA expression and methylation of the intron-2 CpGs. Nevertheless, an inverse 342 correlation between CSTA expression and methylation in the upstream CpG sites was observed (Fig. 4E ).
343
The ENCODE project data corresponding to MCF-7 and T47D cells, and our bisulfite sequencing results 344 clearly demonstrated that CSTA expression, and methylation in the intron-2 CpGs, are inversely correlated.
345
Collectively, these data provide compelling evidence in favor of DNA methylation-dependent silencing of 346 CSTA in breast cancer cells. Altered Cathepsin B: CSTA ratio in breast tumors is reported. It also correlates 347 with disease prognosis (Lah et al., 1997 (Lah et al., , 1992 Levicar et al., 2002) . Ablation or inhibition of Cathepsin B 348 also inhibits spine and lung metastasis in the animal model (Withana et al., 2012) . We therefore, propose 
365
However, the mechanism of estrogen-mediated regulation of CSTA is more complex. Estrogen does not 366 produce similar effects on CSTA expression in ERα positive breast cancer cell lines. Estrogen suppresses 367 CSTA expression in ZR-75-1 cells. However, the extent of suppression is much lower than that observed 368 in MCF-7 cells. In T47D cells, estrogen does not modulate CSTA expression. The study offers no insight 369 into the reasons behind differential responses of the breast cancer cell lines to estrogen stimulation.
370
However, it highlights the role of intron-2 methylation in estrogen regulation of CSTA.
371
Here we have analyzed two specific regions, namely Region 1 and Region 2, that encompass few 372 of the upstream and intron-2 CpG sites, respectively. While it is worth analyzing methylation at every CpG site in the CSTA locus, our study shows that intron-2 is the site of convergence of estrogen regulation and 374 DNA methylation-dependent silencing. Interestingly, the ERα binding site is located amidst the intron-2 375 CpGs analyzed in this study. Our global demethylation experiments with MDA-MB-231 and T47D cells 376 revealed the conflict between ERα binding and DNA methylation in region-2. Due to methylation-377 dependent silencing, MDA-MB-231 cells do not express ERα (Lapidus et al., 1998; Ottaviano et al., 1994) 378 and CSTA ( 
389
The relationship between DNA methylation and transcription is not a one-way interaction. In a 390 given genomic locus, the transcriptional activity can limit DNA methylation. In Arabidopsis, this is evident 391 from the distribution of methylated and transcriptionally active loci (Zilberman et al., 2007) .
392
Pharmacological inhibition of RNA polymerase II induces repressive histone modification, which results 393 in epigenetic silencing. It is possible that repressive histone modification also leads to DNA methylation.
394
Thurman and co-workers studied methylation of transcription factor binding sites and transcription factor 395 abundance in DNAse I hypersensitive sites. They found an inverse correlation between the expression level 396 of a given transcription factor and methylation of the cognate binding site. This suggests a model of "passive 397 DNA methylation" (Thurman et al., 2012) . On the other hand, methylation of cytosine residues in CpG 398 dinucleotides prevents binding of transcription factors to their cognate response elements on DNA (Choy   399   et al., 2010; Comb and Goodman, 1990; Miranda and Jones, 2007; Prendergast et al., 1991) (Ung et al., 2014) . results from MDA-MB-231 and T47D showed that demethylation can restore estrogen regulation at the 416 CSTA locus. We believe that this is most likely due to the restoration of the ERα access to the ERE.
417
Taken together, the present study shows that CSTA expression in breast cancer cells is inversely 418 related to DNA methylation in the CSTA locus. It explains the loss of CSTA expression in breast tumors.
419
This result may be exploited for predicting CSTA expression or metastatic progression of breast tumors. Afgan, E., Baker, D., van den Beek, M., Blankenberg, D., Bouvier, D., Čech, M., Chilton, J., Clements, 499 D., Coraor, N., Eberhard, C., Grüning, B., Guerler, A., Hillman-Jackson, J., Von Kuster, G., Rasche, 500 E., Soranzo, N., Turaga, N., Taylor, J., Nekrutenko, A., Goecks, J., 2016. 
